Primary therapy and relative survival in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia: a population‐based study in the Netherlands, 1989

Primary therapy and relative survival in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia: a population‐based study in the Netherlands, 1989–2018

Published:2021-10-03 Issue:3 Volume:196 Page:660-669
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Amaador Karima¹^ORCID,Kersten Marie José¹,Visser Otto²,Brink Mirian³,Posthuma Eduardus F. M.⁴⁵,Minnema Monique C.⁶,Vos Josephine M. I.¹,Dinmohamed Avinash G.¹³⁷⁸^ORCID

Affiliation:

1. Amsterdam UMC Department of Hematology University of Amsterdam Cancer Center Amsterdam LYMMCARE Amsterdamthe Netherlands

2. Department of Registration Netherlands Comprehensive Cancer Organisation (IKNL) Utrechtthe Netherlands

3. Department of Research and Development Netherlands Comprehensive Cancer Organisation (IKNL) Utrechtthe Netherlands

4. Department of Internal Medicine Reinier de Graaf Gasthuis Delftthe Netherlands

5. Department of Hematology Leiden University Medical Center Leidenthe Netherlands

6. Department of Hematology University Medical Center Utrecht University Utrecht Utrechtthe Netherlands

7. Department of Public Health Erasmus MC University Medical Center Rotterdam Rotterdamthe Netherlands

8. Amsterdam UMC Department of Hematology Vrije Universiteit Amsterdam Cancer Center Amsterdam Amsterdam the Netherlands

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17856

Reference38 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

2. Guideline for diagnosis and treatment of Waldenström's macroglobulinaemia;Vos JM;Neth J Med,2013

3. Waldenström macroglobulinemia: a Surveillance, Epidemiology, and End Results database review from 1988 to 2005

4. Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic Review

5. Waldenström Macroglobulinemia: Review of Pathogenesis and Management

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New developments in the diagnosis and characterization of Waldenström’s macroglobulinemia;Expert Review of Hematology;2023-11-02

2. Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management;American Journal of Hematology;2023-01

3. First-Line Treatment of Waldenström’s Macroglobulinaemia: Considerations Based on the Dutch National Guideline;Hemato;2022-10-26

4. Treatment of relapsed and refractory Waldenstrom Macroglobulinemia;Leukemia & Lymphoma;2022-10-25

5. Baseline 18F-FDG PET/CT May Portend the Prognosis of Patients With Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma After First-Line Treatment;Clinical Nuclear Medicine;2022-08-16